mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.01 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |